127 related articles for article (PubMed ID: 37778510)
1. APOE-Genotype and Insulin Modulate Estimated Effect of Dietary Macronutrients on Cognitive Performance: Panel Analyses in Nondiabetic Older Adults at Risk of Dementia.
Norgren J; Sindi S; Matton A; Kivipelto M; Kåreholt I
J Nutr; 2023 Dec; 153(12):3506-3520. PubMed ID: 37778510
[TBL] [Abstract][Full Text] [Related]
2. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
[TBL] [Abstract][Full Text] [Related]
3. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
[TBL] [Abstract][Full Text] [Related]
4. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
6. APOE ε 4 allele and CSF APOE on cognition in HIV-infected subjects.
Andres MA; Feger U; Nath A; Munsaka S; Jiang CS; Chang L
J Neuroimmune Pharmacol; 2011 Sep; 6(3):389-98. PubMed ID: 21184197
[TBL] [Abstract][Full Text] [Related]
7. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
8. Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.
Liu X; Beck T; Dhana K; Tangney CC; Desai P; Krueger K; Evans DA; Rajan KB
J Nutr Health Aging; 2024 May; 28(5):100211. PubMed ID: 38507884
[TBL] [Abstract][Full Text] [Related]
9. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.
Hanson AJ; Bayer-Carter JL; Green PS; Montine TJ; Wilkinson CW; Baker LD; Watson GS; Bonner LM; Callaghan M; Leverenz JB; Tsai E; Postupna N; Zhang J; Lampe J; Craft S
JAMA Neurol; 2013 Aug; 70(8):972-80. PubMed ID: 23779114
[TBL] [Abstract][Full Text] [Related]
10. The Dietary Carbohydrate/Fat-Ratio and Cognitive Performance: Panel Analyses in Older Adults at Risk for Dementia.
Norgren J; Sindi S; Sandebring-Matton A; Ngandu T; Kivipelto M; Kåreholt I
Curr Dev Nutr; 2023 Jun; 7(6):100096. PubMed ID: 37275847
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
13. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.
Seshadri S; Drachman DA; Lippa CF
Arch Neurol; 1995 Nov; 52(11):1074-9. PubMed ID: 7487559
[TBL] [Abstract][Full Text] [Related]
15. Association of the epsilon 4 allele of apolipoprotein E with poor performance on a dementia screen in African Americans.
Hui SL; Gao S; Hall KS; Sahota A; Hendrie HC
Ethn Dis; 1996; 6(3-4):266-71. PubMed ID: 9086316
[TBL] [Abstract][Full Text] [Related]
16. The effect of the ApoE genotype on the association between head circumference and cognition.
Kim KR; Lee KS; Kim EA; Cheong HK; Oh BH; Hong CH
Am J Geriatr Psychiatry; 2008 Oct; 16(10):819-25. PubMed ID: 18827228
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.
Lasser RA; Dukoff R; Levy J; Levin R; Lehtimäki T; Seubert P; Sunderland T
Int J Geriatr Psychiatry; 1998 Nov; 13(11):767-74. PubMed ID: 9850873
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
Yip AG; Brayne C; Easton D; Rubinsztein DC;
J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition.
Corder EH; Lannfelt L; Viitanen M; Corder LS; Manton KG; Winblad B; Basun H
Arch Neurol; 1996 May; 53(5):418-22. PubMed ID: 8624216
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults.
Mauricio M; O'Hara R; Yesavage JA; Friedman L; Kraemer HC; Van De Water M; Murphy GM
Am J Geriatr Psychiatry; 2000; 8(3):196-200. PubMed ID: 10910416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
